CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. The company is headquartered in Brentwood, Tennessee and currently employs 684 full-time employees. The company went IPO on 2015-07-24. The firm operates through two segments: segments: Life Sciences Services and Life Sciences Products. Its life sciences services include BioLogistics and BioStorage/BioServices, which provides temperature-controlled logistics, biostorage and bioservices within the life science industry through direct sales. Its life sciences products segment manufactures and sells cryogenic systems, such as freezers and cryogenic dewars and related ancillary accessories used in the storage and transport of life science commodities through direct sales or a distribution network. Its operating units include Cryoport Systems, CryoGene and MVE Biological Solutions (MVE). Cryoport Systems provides temperature-controlled BioLogistics, BioServices, and cryopreservation solutions, supporting clinical and commercial workflows through transport, kit production, labeling, packaging, and others.
Mr. Jerrell Shelton 2012 'den beri şirketle birlikte olan Cryoport Inc 'in Chairman of the Board 'ıdır.
CYRX hissesinin fiyat performansı nasıl?
CYRX 'in mevcut fiyatı $13.86 'dir, son işlem günde 1% 감소된 etti.
Cryoport Inc için ana iş temaları veya sektörler nelerdir?
Cryoport Inc Life Sciences Tools & Services endüstrisine ait ve sektör Health Care 'dir
Cryoport Inc 'in piyasa değerlemesi nedir?
Cryoport Inc 'in mevcut piyasa değerlemesi $691.0M 'dir
Cryoport Inc al, sat, yoksa beklemeli mi?
Wall Street analistlerine göre, 12 analist Cryoport Inc için analist derecelendirmeleri gerçekleştirdi, bunlar 6 güçlü al, 7 al, 2 tut, 0 sat ve 6 güçlü sat içermektedir